Seroquel IR

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

EfficacyAnxiety

145 competitors in Efficacy

#DrugCompanyPhaseTrials

1

Oncovin

Eli Lilly

Phase 3

42

Tivicay

GSK

Phase 3

23

Rogaine

Pfizer

Phase 3

14

Rayos

RRoxane Laboratories

Phase 3

55

Paraplatin

AAvyxa

Phase 3

46

Alimta

SShawn Eagle

Phase 3

37

Cytoxan

BBaxter Healthcare Corporation

Phase 3

38

Lesinurad

EEsperion Therapeutics, Inc.

Phase 3

29

Insulin 320

Novo Nordisk

Phase 3

510

Pifeltro

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Phase 3

1Show 37 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

ISS1 trial

Positron Emission Tomography (PET) Study With [11C]Raclopride to Determine Central D2 Dopamine Occupancy of SEROQUEL

Completed·AstraZeneca·Phase 1·NCT00832221·10 enrolled

Major Depressive Disorder1 trial

A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial

Completed·Otsuka·Phase 3·NCT01727726·2,182 enrolled

Anxiety1 trial

Generalized Anxiety and Seroquel

Terminated·MMclean Hospital·N/A·NCT01066143·8 enrolled

Efficacy1 trial

Efficacy of Extended-release Quetiapine (Seroquel XR) as Adjunctive Therapy to Cognitive Behavioral Therapy in the Treat

Completed·IIcahn School of Medicine at Mount Sinai·N/A·NCT01971203·62 enrolled

Alcohol Dependence1 trial

Trial of Seroquel SR for Alcohol Dependence and Comorbid Anxiety

Completed·—·Phase 4·NCT00352469·20 enrolled

1 more indication

Bipolar Disorder1 trial

Trial to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolar Disorder

Completed·Otsuka·Phase 1·NCT03872596·58 enrolled

Details

Drug Info

Related News